Key points are not available for this paper at this time.
N-methyl-D-aspartate receptors (NMDARs) are the main class of ionotropic receptor for the ex-citatory neurotransmitter glutamate. It plays a crucial role in the permeability of Ca2+ ions and excitatory neurotransmission in the brain. Being heteromeric receptors, they are composed of sev-eral subunits, including two obligatory GluN1 subunits (eight splice variants) and regulatory GluN2 (GluN2A~D) and/or GluN3 (GluN3A~B) subunits. Widely distributed in the brain, they regulate other neurotransmission systems and are therefore involved in essential functions such as synaptic transmission, learning and memory, plasticity, excitotoxicity. The present review will discuss the physiopathological impacts of NMDAR and particularly GluN2A and GluN2B subu-nits in cognitive processes and neurodegenerative diseases (Alzheimers disease, Huntingtons disease, Parkinsons disease). The pharmacology of different NMDAR antagonists and their po-tentialities will be presented. In particular, a focus will be given on fluoroethylnormemantine (FENM), an investigational drug with very promising developments as a tomography radiotracer for NMDARs, an anxiolytic in post-traumatic stress disorder and a neuroprotective agent in Alzheimers disease.
Building similarity graph...
Analyzing shared references across papers
Loading...
Allison Carles
Aline Freyssin
Florent Perin-Dureau
Inserm
Université de Montpellier
École Pratique des Hautes Études
Building similarity graph...
Analyzing shared references across papers
Loading...
Carles et al. (Mon,) studied this question.
www.synapsesocial.com/papers/68e7982fb6db6435877080d0 — DOI: https://doi.org/10.20944/preprints202402.0679.v1